Lysosomes, the essential organelle for cellular waste and pathogen clearance through all autophagic and endocytic pathways, are highly vulnerable in aging neurons and strongly implicated in neurodegenerative disease pathogenesis, particularly Alzheimer?s Disease (AD). We showed that presenilin 1 (PS1) is required for vATPase activity necessary to acidify lysosomes and initiate digestion: loss of PS1 function in familial AD impedes substrate degradation, leading to neuronal dysfunction and AD-related pathology. Recently, we reported that the direct molecular trigger of the endosomal dysfunction linked to cholinergic neurodegeneration in AD is the APP ?-site cleaved C-terminal fragment (?CTF) (studied in Projects 1, 3, and 4). Our newest data indicate a significant impact of ?CTF on lysosome function, including impaired acidification. Our working hypothesis is that other risk factors, including ones for late-onset AD (ApoE4, cholesterol, brain aging), impair lysosomal function by ?CTF-dependent and -independent mechanisms. Much of this lysosomal dysfunction stems from the compromise of vATPase, occuring via multiple mechanisms shown to disrupt its function and thereby raise lysosomal pH and promote neurodegeneration. In 3 specific aims, we address both the mechanisms underlying pathogenic lysosomal dysfunction in AD and strategies to remediate this dysfunction.
In Aim 1, we will define the molecular basis for lysosomal dysfunction in a late-onset AD model of wild-type APP overexpression and a Down syndrome model with known ?CTF-driven endosome phenotypes in comparison to models in which lysosome compromise is induced by known AD risk factors (ApoE4 genotype and dietary fat/cholesterol). Models in which ?CTF are also experimentally modulated will be used to ascertain the nature and extent of the ?CTF contributions, believed to be major, in compromising lysosomal pH regulation, substrate hydrolysis, and signaling functions. A novel role of chaperone-mediated autophagy (CMA) in ?CTF metabolism will be assessed in relation to known aging-related declines in the efficiency of CMA and lysosomes.
In Aim 2, we will define in neurons and isolated lysosomes multiple suspected mechanisms underlying the loss of vATPase function seen in AD models.
In Aim 3, we will characterize a novel lysosomal pH modulation mechanism via the ClC7 chloride channel and the basis for its ability to reverse acidification deficits and fully rescue lysosomal and autophagy deficits in PS1 deficient and FAD patient cells. The detailed mechanism by which certain beta-adrenergic agonists induce this rescue, the applicability of this remediation to non-PS AD models, and the evaluation of more optimal brain-penetrant compounds that promote lysosomal acidification are additional goals of Aim 3. Novel genetic models with altered endosomal-lysosomal function or that report on neuronal lysosomal network function in vivo are introduced in our project and serve to enhance expectations that we will make fundamental insights into lysosome biology relevant to AD and its therapy.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Research Program Projects (P01)
Project #
2P01AG017617-16
Application #
9279740
Study Section
Special Emphasis Panel (ZAG1-ZIJ-7 (J1))
Project Start
Project End
Budget Start
2017-04-01
Budget End
2018-03-31
Support Year
16
Fiscal Year
2017
Total Cost
$451,071
Indirect Cost
$153,170
Name
Nathan Kline Institute for Psychiatric Research
Department
Type
Research Institutes
DUNS #
167204762
City
Orangeburg
State
NY
Country
United States
Zip Code
10962
Lee, Ju-Hyun; Rao, Mala V; Yang, Dun-Sheng et al. (2018) Transgenic expression of a ratiometric autophagy probe specifically in neurons enables the interrogation of brain autophagy in vivo. Autophagy :1-15
Alldred, Melissa J; Chao, Helen M; Lee, Sang Han et al. (2018) CA1 pyramidal neuron gene expression mosaics in the Ts65Dn murine model of Down syndrome and Alzheimer's disease following maternal choline supplementation. Hippocampus 28:251-268
Jeanneteau, Freddy; Barrère, Christian; Vos, Mariska et al. (2018) The Stress-Induced Transcription Factor NR4A1 Adjusts Mitochondrial Function and Synapse Number in Prefrontal Cortex. J Neurosci 38:1335-1350
Peng, Katherine Y; Pérez-González, Rocío; Alldred, Melissa J et al. (2018) Apolipoprotein E4 genotype compromises brain exosome production. Brain :
Ginsberg, Stephen D; Alldred, Melissa J; Gunnam, Satya M et al. (2018) Expression profiling suggests microglial impairment in human immunodeficiency virus neuropathogenesis. Ann Neurol 83:406-417
Tiernan, Chelsea T; Ginsberg, Stephen D; He, Bin et al. (2018) Pretangle pathology within cholinergic nucleus basalis neurons coincides with neurotrophic and neurotransmitter receptor gene dysregulation during the progression of Alzheimer's disease. Neurobiol Dis 117:125-136
Kaur, Gurjinder; Gauthier, Sebastien A; Perez-Gonzalez, Rocio et al. (2018) Cystatin C prevents neuronal loss and behavioral deficits via the endosomal pathway in a mouse model of down syndrome. Neurobiol Dis 120:165-173
Colacurcio, Daniel J; Pensalfini, Anna; Jiang, Ying et al. (2018) Dysfunction of autophagy and endosomal-lysosomal pathways: Roles in pathogenesis of Down syndrome and Alzheimer's Disease. Free Radic Biol Med 114:40-51
Pacheco-Quinto, Javier; Clausen, Dana; Pérez-González, Rocío et al. (2018) Intracellular metalloprotease activity controls intraneuronal A? aggregation and limits secretion of A? via exosomes. FASEB J :fj201801319R
East, Brett S; Fleming, Gloria; Peng, Kathy et al. (2018) Human Apolipoprotein E Genotype Differentially Affects Olfactory Behavior and Sensory Physiology in Mice. Neuroscience 380:103-110

Showing the most recent 10 out of 163 publications